Literature DB >> 27345094

The Impact of Dominant Ventricle Morphology on Palliation Outcomes of Single Ventricle Anomalies.

Bahaaldin Alsoufi1, Scott Gillespie2, Dennis Kim2, Subhadra Shashidharan3, Kirk Kanter3, Kevin Maher2, Brian Kogon3.   

Abstract

BACKGROUND: Differences in right ventricle and tricuspid valve structure compared with left ventricle and mitral valve structure make them less equipped to support the systemic circulation long term, with subsequent systemic right ventricle failure. We examined the effect of dominant ventricle morphology on single ventricle palliation outcomes.
METHODS: We grouped 530 neonates who underwent first-stage palliation into two groups based on dominant ventricle morphology: right dominant ventricle (RV group; n = 302, 57%) and left dominant ventricle or functional single ventricle with two well-formed ventricles (LV group; n = 228, 43%). Comparisons of hospital outcomes, interstage mortality, progression to subsequent palliation stages, and late survival was performed, and factors affecting outcomes were examined.
RESULTS: After first-stage palliation, the RV group and LV group, respectively, had comparable extracorporeal membrane oxygenation requirements (12% versus 11%, p = 0.648), unplanned reoperation (12% versus 13%, p = 0.586), and hospital death (16% versus 13%, p = 0.437). Among hospital survivors, interstage mortality (11% versus 9%, p = 0.509) and progression to Glenn operation (89% versus 84%, p = 0.182) were comparable; however, death after Glenn was higher in the RV group (10%, versus LV group 4%, p = 0.020) with a trend for lower 8-year survival (66% versus 73%, p = 0.081). On multivariable analysis, dominant RV was not associated with mortality (hazard ratio 0.75, 95% confidence interval: 0.6 to 1.0, p = 0.081), whereas factors such as genetic syndromes, weight 2.5 kg or less, underlying cardiac anomaly, and first-stage palliation type affected survival.
CONCLUSIONS: At midterm follow-up, underlying cardiac anomaly and patient characteristics affect single ventricle palliation outcomes more than dominant ventricular morphology. As right ventricle and associated tricuspid valve failure might occur at late stages, the impact of dominant ventricular morphology on long-term outcomes requires further assessment.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27345094     DOI: 10.1016/j.athoracsur.2016.04.054

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  Heart failure in single right ventricle congenital heart disease: physiological and molecular considerations.

Authors:  Anastacia M Garcia; Jonathan-Thomas Beatty; Stephanie J Nakano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-28       Impact factor: 4.733

2.  An Early Glenn Operation May be Associated with the Later Occurrence of Protein-Losing Enteropathy in Fontan Patients : Association of Early Glenn and Failing Fontan.

Authors:  Bettina Unseld; Brigitte Stiller; Thomas Borth-Bruhns; Florian du Bois; Johannes Kroll; Jochen Grohmann; Thilo Fleck
Journal:  Pediatr Cardiol       Date:  2017-05-22       Impact factor: 1.655

3.  Relationship of Ventricular Morphology and Atrioventricular Valve Function to Long-Term Outcomes Following Fontan Procedures.

Authors:  Jiyong Moon; Li Shen; Donald S Likosky; Vikram Sood; Reilly D Hobbs; Peter Sassalos; Jennifer C Romano; Richard G Ohye; Edward L Bove; Ming-Sing Si
Journal:  J Am Coll Cardiol       Date:  2020-07-28       Impact factor: 24.094

4.  Loss of Ventricular Function After Bidirectional Cavopulmonary Connection: Who Is at Risk?

Authors:  Marie Vincenti; M Yasir Qureshi; Talha Niaz; Drew K Seisler; Timothy J Nelson; Frank Cetta
Journal:  Pediatr Cardiol       Date:  2020-08-11       Impact factor: 1.655

Review 5.  Right ventricular phenotype, function, and failure: a journey from evolution to clinics.

Authors:  Yannick J H J Taverne; Amir Sadeghi; Beatrijs Bartelds; Ad J J C Bogers; Daphne Merkus
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.